Moneycontrol
Aug 10, 2017 01:23 PM IST | Source: Moneycontrol.com

Genomic Valley Biotech's board meeting rescheduled on September 13, 2017

Revised Notice is hereby given that the Meeting of Board of Directors of the Company will be held on Wednesday, 13.09.2017 at 11.45 A.M. at G-74, Pushkar Enclave, Paschim Vihar, Delhi-110063, inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and three months ended 30.06.2017(Q1).'

Genomic Valley Biotech's board meeting rescheduled on September 13, 2017
The Company is facing difficulty for converting accounting data from GAAP to Ind AS (applicable from 01.04.2017),the Company has decided to postpone its Board Meeting to consider and approve the Un-Audited Financial Results for the quarter and three months ended 30.06.2017, which has been scheduled to be held on 12.08.2017.
'Revised Notice is hereby given that the Meeting of Board of Directors of the Company will be held on Wednesday, 13.09.2017 at 11.45 A.M. at G-74, Pushkar Enclave, Paschim Vihar, Delhi-110063, inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and three months ended 30.06.2017(Q1).'
The trading window,as defined under Reg 30 of SEBI (LODR) Reg, 2015 and SEBI (PIT) Reg, 2015, which is closed from 03.08.2017 has been opened, with further closure from 04.09.2017 till 48 hours after announcement of financial results for the quarter ended 30.06.2017 to public.Source : BSE
Sections
Follow us on
Available On